Brief: Atreca Announces Expansion Of Preclinical Pipeline
05/04/2022 21:10
April 5 (Reuters) - Atreca Inc BCEL.O :
* ATRECA ANNOUNCES EXPANSION OF PRECLINICAL PIPELINE
* ATRECA INC - ANNOUNCED A LICENSING AGREEMENT WITH
ZYMEWORKS INC
* ATRECA INC - AS PART OF AGREEMENT WITH ZYMEWORKS, CO'S
ANTIBODIES WILL BE CONJUGATED USING ZYMELINK
Source text for Eikon: ID:nGNXc6Q05S
Further company coverage: BCEL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Atreca
See all newsBrief: Baker Bros Advisors Reports 19.99% Passive Stake In Atreca As Of Dec 31, 2023 - SEC Filing
Brief: Immunome To Acquire Antibody-Related Assets And Materials From Atreca
Brief: Atreca Says On Dec 19 Asset Sale And Other Transactions Contemplated By Agreement, Board Approved Liquidation And Dissolution Of Co
Brief: Atreca Q3 basic EPS USD -0.92
Brief: Atreca Announces Agreement To Terminate Lease And Departure Of CFO Herb Cross